A new blood test employing whole-genome sequencing (WGS) demonstrates a groundbreaking 99% sensitivity and specificity for detecting HPV-positive head and neck cancers, significantly outperforming current standard methods.
Just Healthcare is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid…
Continue reading this post for free, courtesy of Naveen Sankar S.